LIGAND-SPECIFIC NON-ANTIBODY COMPOUNDS THAT INHIBIT CR2 ACTIVATION AND METHODS OF USE THEREOF

摘要

The present invention describes a novel non-antibody ligand- specific compound that selectively binds to a complement receptor type 2 (CR2) protein, a ligand thereof, or both, wherein the compound competitively inhibits CR2 ligand' s binding to a CR2 protein in a standard assay. The present invention also describes compositions and methods of use thereof.